EPO Patent EP4499113A1: Polymeric Iron Binding Compositions for Disease Treatment
Summary
The European Patent Office has published patent application EP4499113A1 for polymeric iron binding compositions and methods of use for treating diseases associated with excess damaging reactive iron. The patent application was filed by FE PHARMACEUTICALS (CANADA) INC. and lists Bruce E. Holbein, M. Trisha C. Ang, and Roger Gumbau-Brisa as inventors.
What changed
This document is a publication of a European patent application (EP4499113A1) concerning polymeric iron binding compositions for treating diseases linked to excess reactive iron. The application was filed by FE PHARMACEUTICALS (CANADA) INC. and includes specific International Patent Classification (IPC) codes related to pharmaceutical preparations and polymer chemistry.
This patent publication does not impose any new regulatory obligations or compliance deadlines on regulated entities. It represents the grant of intellectual property rights for a specific invention and is primarily relevant for R&D, patent law, and competitive intelligence within the pharmaceutical sector.
Source document (simplified)
POLYMERIC IRON BINDING COMPOSITIONS AND METHODS OF USE FOR TREATING DISEASES ASSOCIATED WITH EXCESS DAMAGING REACTIVE IRON
Publication EP4499113A1 Kind: A1 Mar 18, 2026
Applicants
FE PHARMACEUTICALS (CANADA) INC.
Inventors
HOLBEIN, Bruce E., ANG, M. Trisha C., GUMBAU-BRISA, Roger
IPC Classifications
A61K 31/79 20060101AFI20260206BHEP A61K 45/06 20060101ALI20260206BHEP A61P 39/04 20060101ALI20260206BHEP C08F 220/54 20060101ALI20260206BHEP C08F 220/60 20060101ALI20260206BHEP C08F 226/10 20060101ALI20260206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.